SYNLAB’s Acquisition of Yhtyneet Medix Laboratoriot Oy


White & Case LLP has advised SYNLAB on the acquisition of Yhtyneet Medix Laboratoriot Oy (YML), Finland’s leading private laboratory company, from Medix Laboratoriot Oy and Yhtyneet Laboratoriot Oy.

SYNLAB Group, the European market leader in medical diagnostic services, offers the full range of innovative and reliable medical diagnostics for patients, practicing doctors, clinics and the pharmaceutical industry. The acquisition of YML is an important step in SYNLAB’s expansion strategy in the Finnish market.

YML offers comprehensive central laboratory services in clinical chemistry, clinical microbiology, pathology and genetics as well as in therapeutic drug testing, drugs of abuse testing and doping control in sports.

The White & Case team in Helsinki which advised on the transaction was led by partner Janko Lindros (Picture) and included associates Essi Lavikkala, Eerika Halme and Emma Nyyssölä.

Involved fees earner: Janko Lindros – White & Case; Essi Lavikkala – White & Case; Eerika Halme – White & Case; Emma Nyyssölä – White & Case;

Law Firms: White & Case;

Clients: Synlab International GmbH;